Relations between vasoactive hormones and diastolic function in hypertensive uraemic patients

Related Experiment Video

Updated: Nov 3, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

C Napoli1, A Liguori, P Sorice

  • 1Department of Medicine, Regional Hospital of Pellegrini, Italy.

Journal of Internal Medicine
|December 1, 1996
PubMed

Insights

Elevated endothelin-1 (ET-1) levels correlate with diastolic dysfunction in chronic uraemic patients. This finding suggests ET-1 as a potential early marker for cardiac disease, enabling timely therapeutic interventions.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Arterial hypertension is a major cardiovascular disease risk factor in chronic uraemia (CU).
  • Hormonal factors may serve as early cardiac disease markers in CU patients.
  • Understanding hypertension's role in CU patient outcomes is critical.

Purpose of the Study:

  • Investigate hormone roles in CU patient cardiac diastolic properties.
  • Examine the association between hypertension, diastolic function, and vasoactive hormone release in CU patients.
  • Clarify endothelin-1's (ET-1) effect on diastolic function.

Main Methods:

  • Assessed cardiac diastolic function and plasma hormone levels in hypertensive CU patients.
  • Correlated atrial natriuretic factor and ET-1 levels with diastolic function.
  • Investigated ET-1's correlation with diastolic function (E/A ratio) in non-uraemic patients.

Main Results:

  • Early diastolic dysfunction in hypertensive CU patients correlated with elevated atrial natriuretic factor and ET-1.
  • A significant inverse correlation was found between E/A ratio and ET-1 plasma concentrations in non-uraemic patients.
  • Hypertension was associated with impaired diastolic function and altered vasoactive hormone release.

Conclusions:

  • Elevated ET-1 levels are strongly correlated with diastolic dysfunction in humans.
  • This association has significant pathophysiological implications for CU patients.
  • Suggests potential for early therapeutic strategies targeting ET-1 in CU patients.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...